These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 821309)

  • 61. Differential effect of phenobarbital and beta-naphthoflavone on the mRNAs coding for cytochrome P450 and NADPH cytochrome P450 reductase.
    Shephard EA; Phillips IR; Pike SF; Ashworth A; Rabin BR
    FEBS Lett; 1982 Dec; 150(2):375-80. PubMed ID: 6186523
    [No Abstract]   [Full Text] [Related]  

  • 62. Presence of the NADPH-cytochrome P-450 reductase system in liver and kidney mitochondria.
    Ohashi M; Omura T
    J Biochem; 1978 Jan; 83(1):249-60. PubMed ID: 415057
    [No Abstract]   [Full Text] [Related]  

  • 63. Liver microsomal drug-metabolizing enzyme system: functional components and their properties.
    Lu AY
    Fed Proc; 1976 Nov; 35(13):2460-3. PubMed ID: 824157
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Immunohistochemical studies on electron transport proteins associated with cytochromes P-450 in steroidogenic tissues. II. Microsomal NADPH-cytochrome c reductase in the rat adrenal.
    Taira Y; Redick JA; Greenspan P; Baron J
    Biochim Biophys Acta; 1979 Mar; 583(2):148-58. PubMed ID: 109128
    [TBL] [Abstract][Full Text] [Related]  

  • 65. D-amphetamine, imipramine and ethanol metabolizing enzymes.
    Messiha FS; Larson JW; Lox CD
    Proc West Pharmacol Soc; 1978; 21():277-80. PubMed ID: 693508
    [No Abstract]   [Full Text] [Related]  

  • 66. The microsomal ethanol oxidizing system (MEOS).
    Lieber CS; DeCarli LM; Matsuzaki S; Ohnishi K; Teschke R
    Methods Enzymol; 1978; 52():355-67. PubMed ID: 97494
    [No Abstract]   [Full Text] [Related]  

  • 67. NADPH-cytochrome P-450 reductase of yeast microsomes.
    Aoyama Y; Yoshida Y; Kubota S; Kumaoka H; Furumichi A
    Arch Biochem Biophys; 1978 Jan; 185(2):362-9. PubMed ID: 415662
    [No Abstract]   [Full Text] [Related]  

  • 68. Specific requirement of NADPH-cytochrome c reductase for the microsomal heme oxygenase reaction yielding biliverdin IX alpha.
    Noguchi M; Yoshida T; Kikuchi G
    FEBS Lett; 1979 Feb; 98(2):281-4. PubMed ID: 105935
    [No Abstract]   [Full Text] [Related]  

  • 69. The influence of age and of the inducer phenobarbital on the cytochrome P-450 dependent monooxygenation of drugs in rat liver.
    Müller D; Klinger W
    Pharmazie; 1978 Jul; 33(7):397-400. PubMed ID: 103104
    [No Abstract]   [Full Text] [Related]  

  • 70. Effect of phenobarbitone on hepatic drug-metabolizing enzymes and urinary D-glucaric acid excretion in man.
    Lecamwasam DS; Franklin C; Turner P
    Br J Clin Pharmacol; 1975 Jun; 2(3):257-62. PubMed ID: 1234506
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The role of NADPH-cytochrome c reductase in microsomal hydroxylation reactions.
    Prough RA; Burke MD
    Arch Biochem Biophys; 1975 Sep; 170(1):160-8. PubMed ID: 809012
    [No Abstract]   [Full Text] [Related]  

  • 72. NADPH-cytochrome c reductase of Candida tropicalis grown on alkane.
    Bertrand JC; Bazin H; Zacek M; Gilewicz M; Azoulay E
    Eur J Biochem; 1979 Jan; 93(2):237-43. PubMed ID: 107026
    [No Abstract]   [Full Text] [Related]  

  • 73. Effect of phenobarbital and 3-methylcholanthrene treatment on NADPH- and NADH-dependent production of reactive oxygen intermediates by rat liver nuclei.
    Puntarulo S; Cederbaum AI
    Biochim Biophys Acta; 1992 Mar; 1116(1):17-23. PubMed ID: 1311603
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Interactions between spinach ferredoxin and other electron carriers. The involvement of a ferredoxin:cytochrome c complex in the ferredoxin-linked cytochrome c reductase activity of ferredoxin:NADP+ oxidoreductase.
    Davis DJ; San Pietro A
    Arch Biochem Biophys; 1977 Jul; 182(1):266-72. PubMed ID: 196554
    [No Abstract]   [Full Text] [Related]  

  • 75. Induction of microsomal N-hydroxylation of N-2-fluorenylacetamide in rat liver.
    Malejka-Giganti D; McIver RC; Glasebrook AL; Gutmann HR
    Biochem Pharmacol; 1978 Jan; 27(1):61-9. PubMed ID: 413553
    [No Abstract]   [Full Text] [Related]  

  • 76. Participation of microsomal aldehyde reductase in long-chain fatty alcohol synthesis in the rat brain.
    Takahashi N; Saito T; Goda Y; Tomita K
    Biochim Biophys Acta; 1988 Nov; 963(2):243-7. PubMed ID: 3143413
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The influence of phenobarbital administration on hepatic monooxygenase activity at various stages of gestation in the rat.
    Dean ME; Stock BH
    Drug Metab Dispos; 1989; 17(5):579-81. PubMed ID: 2573504
    [No Abstract]   [Full Text] [Related]  

  • 78. Effect of lipid depletion on the kinetics of microsomal NADH-cytochrome C reductase.
    Ishibashi T; Imai Y
    Tohoku J Exp Med; 1976 Apr; 118(4):365-71. PubMed ID: 820017
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effects of phenobarbital, pregnenolone-16 alpha-carbonitrile, and 3-methylcholanthrene pretreatments on the distribution of NADPH-cytochrome c (P-450) reductase within the liver lobule.
    Taira Y; Greenspan P; Kapke GF; Redick JA; Baron J
    Mol Pharmacol; 1980 Sep; 18(2):304-12. PubMed ID: 6775183
    [No Abstract]   [Full Text] [Related]  

  • 80. Effect of riboflavin deficiency on phenobarbital and 3-methylcholanthrene induction of microsomal drug-metabolizing enzymes of the rat.
    Shargel L; Mazel P
    Biochem Pharmacol; 1973 Oct; 22(19):2365-73. PubMed ID: 4147670
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.